CRDF
Cardiff Oncology Inc
NASDAQ: CRDF · HEALTHCARE · BIOTECHNOLOGY
$1.73
+6.79% today
Updated 2026-04-30
Market cap
$117.60M
P/E ratio
—
P/S ratio
198.31x
EPS (TTM)
$-0.69
Dividend yield
—
52W range
$1 – $5
Volume
0.7M
Cardiff Oncology Inc (CRDF) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2004 | 2005 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $650000.00 | $265665.00 | $257696.00 | $450000.00 | $259246.00 | $280000.00 | $313000.00 | $381000.00 | $505000.00 | $378000.00 | $244632.00 | $366000.00 | $359000.00 | $386000.00 | $488000.00 | $683000.00 | $593000.00 |
| Revenue growth (YoY) | — | — | — | -59.1% | -3.0% | +74.6% | -42.4% | +8.0% | +11.8% | +21.7% | +32.5% | -25.1% | -35.3% | +49.6% | -1.9% | +7.5% | +26.4% | +40.0% | -13.2% |
| Cost of revenue | — | — | — | — | — | $1.92M | $3.48M | $15000.00 | $629000.00 | $1.73M | $1.81M | $597000.00 | $11.16M | $11.23M | $500000.00 | $200000.00 | $398000.00 | $404000.00 | $904000.00 |
| Gross profit | — | — | $650000.00 | $265665.00 | $257696.00 | $-1.47M | $-3.22M | $265000.00 | $-316000.00 | $-1.35M | $-1.31M | $-219000.00 | $244632.00 | $366000.00 | $359000.00 | $386000.00 | $488000.00 | $683000.00 | $-311000.00 |
| Gross margin | — | — | 100.0% | 100.0% | 100.0% | -326.7% | -1242.9% | 94.6% | -101.0% | -354.1% | -258.6% | -57.9% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -52.4% |
| R&D | $619635.00 | $1.88M | — | $3.69M | $910685.00 | $1.92M | $3.95M | $6.67M | $10.59M | $15.01M | $7.88M | $8.16M | $11.16M | $11.23M | $17.38M | $27.11M | $32.86M | $36.85M | $35.33M |
| SG&A | $651695.00 | $2.53M | $2.22M | $1.95M | $2.32M | $2.87M | $6.76M | $5.81M | $7.92M | $11.48M | $11.50M | $8.01M | $5.76M | $8.22M | $11.84M | $13.18M | $13.04M | $12.48M | $14.22M |
| Operating income | $-5.38M | $-8.00M | $-2.39M | $-5.38M | $-2.98M | $-4.85M | $-10.69M | $-14.95M | $-25.27M | $-40.15M | $-25.60M | $-17.05M | $-16.68M | $-19.09M | $-28.86M | $-39.90M | $-45.41M | $-48.65M | $-48.96M |
| Operating margin | — | — | -367.7% | -2024.8% | -1155.2% | -1077.6% | -4123.7% | -5337.5% | -8074.8% | -10536.7% | -5068.5% | -4511.4% | -6817.8% | -5214.8% | -8037.6% | -10337.3% | -9305.7% | -7123.1% | -8256.3% |
| EBITDA | $-5.38M | $-8.00M | $-2.17M | $-5.37M | $-2.10M | $-11.53M | $-11.66M | $-14.71M | $-24.89M | $-36.76M | $-22.82M | $-15.70M | $-15.92M | $-18.84M | $-28.40M | $-39.67M | $-45.01M | $-48.25M | $-44.97M |
| EBITDA margin | — | — | -333.6% | -2021.7% | -815.1% | -2561.8% | -4499.0% | -5253.7% | -7953.7% | -9647.9% | -4518.6% | -4153.4% | -6507.7% | -5147.3% | -7912.0% | -10276.2% | -9224.2% | -7064.0% | -7583.8% |
| EBIT | $-5.38M | $-8.00M | $-2.22M | $-5.38M | $-2.11M | $-11.57M | $-11.79M | $-14.95M | $-25.27M | $-37.83M | $-23.87M | $-16.44M | $-16.41M | $-19.30M | $-28.86M | $-39.90M | $-45.41M | $-48.65M | $-45.88M |
| Interest expense | — | — | $90000.00 | $115585.00 | $56636.00 | $0.00 | $17005.00 | $843000.00 | $1.53M | $1.38M | $1.03M | $25409.00 | $234169.00 | $2000.00 | $264000.00 | $1.58M | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-5.37M | $-7.84M | $-2.48M | $-5.45M | $-2.24M | $-11.57M | $-11.81M | $-14.32M | $-27.47M | $-39.20M | $-24.91M | $-16.46M | $-16.41M | $-19.31M | $-28.29M | $-38.70M | $-41.44M | $-45.43M | $-45.88M |
| Net income growth (YoY) | — | -46.0% | +68.4% | -119.7% | +58.9% | -416.5% | -2.1% | -21.3% | -91.8% | -42.7% | +36.5% | +33.9% | +0.3% | -17.6% | -46.5% | -36.8% | -7.1% | -9.6% | -1.0% |
| Profit margin | — | — | -381.5% | -2051.1% | -868.9% | -2570.2% | -4555.9% | -5116.1% | -8776.7% | -10289.8% | -4932.1% | -4354.8% | -6709.7% | -5275.1% | -7880.5% | -10026.9% | -8492.0% | -6651.7% | -7736.3% |